By NZPA
Tuesday 14th January 2003 |
Text too small? |
A spokeswoman for ASIC said the commission had required Tower to make the disclosure. She said it was a prudential issue but would not provide further details as to why the commission had made the requirement.
Tower said that Tower Australia already had excess surplus assets over and above the level required by the Life Insurance Act.
"The decision to increase the level of surplus assets follows a requirement from Apra (the Australian Prudential Regulation Authority) that surplus assets are increased back up to the company's target surplus level quickly.
"The timetable is still under discussion with Apra. The increase is seen by the board as a prudent step to take in rebuilding confidence in its Australian business," Tower said.
Tower Ltd said it would not expect any dividend to be paid from Tower Australia unless its target surplus was met and maintained.
It said it expected to use internal sources of funds in the group to achieve the increase and did not intend to undertake an equity issue to provide funds to cover the requirement.
It also said it did not expect the increase in surplus assets to affect profit projections for the group.
Tower was the target of a mystery buyer seeking 10 percent of the company just before Christmas.
The company has been seen as a takeover target since its stock slumped around 55 percent following a profit warning in November.
It slumped even further when it announced a $75 million annual loss, of which around half was a write-down of its Australian operation, Bridges.
No comments yet
Tower to return 'initial' $70M of capital from sale of life business
Tower shares fall to 2-month low as licensing requirements may weigh on capital returns
Tower's licensing talks with RBNZ may push up minimum solvency requirements
Tower names Hancock as new chief executive, replacing Flannagan
Tower posts first-half profit as asset sales reap gains of $51.4 mln
Fidelity Life acquires most of Tower's life insurance business
Flannagan to leave Tower after strategic review, asset sales
Tower FY profit jumps 67%, to return $120M to shareholders; shares jump
Tower sells medical insurance unit to nib for $102M
Stiassny joins Tower board as questions linger over strategy